Showing 17,641 - 17,660 results of 44,251 for search '(( 5 ((nn decrease) OR (mean decrease)) ) OR ( 50 ((ng decrease) OR (a decrease)) ))', query time: 1.39s Refine Results
  1. 17641

    The effect of bispectral index monitoring on cognitive performance following sedation for outpatient colonoscopy: a randomized controlled trial by Mehmet Sargin (5400356)

    Published 2019
    “…DESIGN AND SETTING: Randomized, controlled trial in a university hospital. METHODS: 100 patients were randomized into two groups. …”
  2. 17642

    The effect of bispectral index monitoring on cognitive performance following sedation for outpatient colonoscopy: a randomized controlled trial by Mehmet Sargin (5400356)

    Published 2019
    “…DESIGN AND SETTING: Randomized, controlled trial in a university hospital. METHODS: 100 patients were randomized into two groups. …”
  3. 17643
  4. 17644

    Supplementary Material for: Hypofractionated Radiotherapy for Anaplastic Thyroid Carcinoma: 15 Years of Experience in a Single Institution by Takahashi N. (4478392)

    Published 2018
    “…<b><i>Conclusions:</i></b> Multivariate analysis showed that an EQD<sub>2</sub> ≥50 Gy resulted in better OS, and hypofractionated radiotherapy decreased the rate of mortality from local recurrence.…”
  5. 17645
  6. 17646
  7. 17647

    Image_1_Identification and characterization of a novel CASR mutation causing familial hypocalciuric hypercalcemia.tif by Chien-Ming Lin (740034)

    Published 2024
    “…In vitro studies, including immunoblotting, immunofluorescence, a cycloheximide chase study, Calbryte™ 520 Ca<sup>2+</sup> detection, and half-maximal effective concentration (EC<sub>50</sub>), were examined.…”
  8. 17648

    Image_2_Identification and characterization of a novel CASR mutation causing familial hypocalciuric hypercalcemia.tif by Chien-Ming Lin (740034)

    Published 2024
    “…In vitro studies, including immunoblotting, immunofluorescence, a cycloheximide chase study, Calbryte™ 520 Ca<sup>2+</sup> detection, and half-maximal effective concentration (EC<sub>50</sub>), were examined.…”
  9. 17649
  10. 17650

    Economic and public health impact of decentralized HIV viral load testing: A modelling study in Kenya by M. de Necker (6407402)

    Published 2019
    “…The GeneXpert system is a diagnostic point-of-care technology that can quantify, amongst others, HIV VL. …”
  11. 17651

    Spontaneous cephalic version and risk factors for persistent breech presentation: a longitudinal retrospective cohort study by Zehong Zhou (6927917)

    Published 2022
    “…Multiparity (aOR, 0.39, 95% CI, 0.30–0.52) and longer gestational weeks at delivery (aOR, 0.50, 95% CI, 0.44–0.56) were associated with a lower risk of persistent breech presentation (PBP). …”
  12. 17652
  13. 17653
  14. 17654

    In vitro fermentation characteristics of ruminant diets using ethanol extract of brown propolis as a nutritional additive by Maria de Fátima Falcão Gomes (12802294)

    Published 2022
    “…Dry matter degradability of diet decreased exponentially as a function of the increase in dose (y = 678.55×dose–0.271). …”
  15. 17655
  16. 17656
  17. 17657

    Breast cancer tumor growth is attenuated by Pt-Mal-LHRH treatment. by Margaret Ndinguri (829018)

    Published 2023
    “…No decrease in body weight was found with Pt-Mal-LHRH treatments (B). …”
  18. 17658

    A multicenter case control study of association of vitamin D with breast cancer among women in Karachi, Pakistan by Uzma Shamsi (8345664)

    Published 2020
    “…</p><p>Results</p><p>Compared to patients with sufficient serum vitamin D (>30 ng/ml), women with serum vitamin D deficiency (<20ng/ml), had a higher risk of breast cancer (OR = 1.65, 95%CI: 1.10, 2.50). …”
  19. 17659

    FGF2 beads produce a more undifferentiated, mouse and human neural stem cell culture. by Steven Lotz (378367)

    Published 2013
    “…<p>(A) Mouse NSCs grown for one week in FGF2beads show increased progenitor cells (Nestin+) and decreased neuronal differentiation (TUJ1+) compared to no FGF2 and soluble FGF2, data quantified in (B). …”
  20. 17660

    Image2_BTBD10 is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma.tif by Jianhui Li (361790)

    Published 2022
    “…<p>Background: BTBD10 serves as an activator of Akt family members through decreasing the protein phosphatase 2A-mediated dephosphorylation. …”